REQUEST A DEMO
Total
USD $0.00
Search more companies

Immuno-Flow,S.R.O. (Czech Republic)

Main Activities: HMO Medical Centers | Medical and Diagnostic Laboratories
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Offices of Physicians
Full name: Immuno-Flow,S.R.O. Profile Updated: November 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Immuno-Flow,S.R.O. is based in Czech Republic, with the head office in Prague. It operates in the HMO Medical Centers sector. It was incorporated on September 30, 1994. There are currently 50 - 99 (2024) people employed by Immuno-Flow,S.R.O.. The latest financial highlights indicate a net sales revenue increase of 16.89% in 2024. Its total assets grew by 18.4% over the same period. In 2024, Immuno-Flow,S.R.O.’s net profit margin increased by 6.47%.

Headquarters
U Pazderek 805/25
Prague; The City of Prague; Postal Code: 18100

Contact Details: Purchase the Immuno-Flow,S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Immuno-Flow,S.R.O. report to view the information.
Registered Capital:
Purchase the Immuno-Flow,S.R.O. report to view the information.
Financial Auditors:
Purchase the Immuno-Flow,S.R.O. report to view the information.
Incorporation Date:
September 30, 1994
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Immuno-Flow,S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
16.89%
Total operating revenue
17.3%
Operating profit (EBIT)
60.87%
EBITDA
50.79%
Net Profit (Loss) for the Period
62.91%
Total assets
18.4%
Total equity
38.41%
Operating Profit Margin (ROS)
8.27%
Net Profit Margin
6.47%
Return on Equity (ROE)
6.94%
Debt to Equity Ratio
-12.6%
Quick Ratio
0.38%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?